alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-QSB
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-END>                                   DEC-31-1996
<CASH>                                         1,619,494
<SECURITIES>                                   6,926,921
<RECEIVABLES>                                  7,402,012
<ALLOWANCES>                                    (917,685)
<INVENTORY>                                    1,381,648
<CURRENT-ASSETS>                              19,094,687
<PP&E>                                        13,987,480
<DEPRECIATION>                                (1,987,142)
<TOTAL-ASSETS>                                49,591,190
<CURRENT-LIABILITIES>                          9,123,682
<BONDS>                                                0
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<COMMON>                                      40,721,233
<OTHER-SE>                                    (5,055,977)
<TOTAL-LIABILITY-AND-EQUITY>                  49,591,190
<SALES>                                       28,637,190
<TOTAL-REVENUES>                              36,944,549
<CGS>                                         15,490,082
<TOTAL-COSTS>                                 30,216,441
<OTHER-EXPENSES>                                (957,726)
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                               436,414
<INCOME-PRETAX>                               (8,240,662)
<INCOME-TAX>                                    (760,000)
<INCOME-CONTINUING>                           (7,480,662)
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                  (7,480,662)
<EPS-PRIMARY>                                      (1.02)
<EPS-DILUTED>                                      (1.02)
        


</TABLE>
# C_2013156EN.01000901.xml

| 1.6.2013 | EN | Official Journal of the European Union | C 156/9 |
| --- | --- | --- | --- |

1.6.2013

EN

Official Journal of the European Union

C 156/9

---

Judgment of the Court (Fourth Chamber) of 11 April 2013 (request for a preliminary ruling from the Landgericht Hamburg — Germany) — Novartis Pharma GmbH v Apozyt GmbH

(Case C-535/11) (1)

1

(Request for a preliminary ruling - Regulation (EC) No 726/2004 - Medicinal products for human use - Procedure for authorisation - Requirement for authorisation - Concept of medicinal products ‘developed’ by means of certain biotechnological processes, as referred to in point 1 of the Annex to that regulation - Repackaging process - Injectable solution distributed in single-use vials containing a larger quantity of the therapeutic solution than that actually used for the purposes of medical treatment - Part of the content of such vials drawn off, on prescription by a doctor, into syringes pre-filled with the prescribed dose, without any modification of the medicinal product)

2013/C 156/13

Language of the case: German

Referring court

Referring court

Landgericht Hamburg

Parties to the main proceedings

Parties to the main proceedings

Applicant: Novartis Pharma GmbH

Applicant:

Defendant: Apozyt GmbH

Defendant:

Re:

Re:

Request for a preliminary ruling — Landgericht Hamburg — Interpretation of the Annex to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ 2004 L 136, p. 1) — Meaning of ‘hergestellt’ (‘developed’ in the English version) in point 1 of that Annex — Whether that term covers the drawing off of liquid medicinal products from the original containers and the transfer into ready-to-use syringes

Operative part of the judgment

Operative part of the judgment

Activities such as those at issue in the main proceedings, provided that they do not result in a modification of the medicinal product concerned and are carried out solely on the basis of individual prescriptions calling for processes of such a kind — a matter which falls to be determined by the referring court —, do not require a marketing authorisation under Article 3(1) of Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, but remain, in any event, subject to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, as amended by Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010.

---

(1)  OJ C 13, 14.1.2012.

1

---
### §3804. Coordination with other Federal departments and agencies

#### (a) Related responsibilities and regulatory activities

In carrying out the programs established under sections 3803 and 3806 of this title, the Secretary shall assure, to the maximum extent practicable, that the functions of this program are coordinated with related regulatory activities and other responsibilities of the Department of Energy and any other Federal departments or agencies.

#### (b) Scope of assistance

Each department, agency, and instrumentality of the executive branch of the Federal Government shall carefully consider any written request from the Secretary, the head of any organizational entity designated by the Secretary pursuant to section 3803(a) of this title, or the head of any agency which is party to an agreement or arrangement pursuant to section 3803(b) of this title, to furnish such assistance, on a reimbursable basis, as the Secretary or such head deems necessary to carry out the program and to achieve the purposes of this chapter. Such assistance may include transfer of personnel with their consent and without prejudice to their position and rating.

(Pub. L. 96–512, §5, Dec. 12, 1980, 94 Stat. 2830.)
Exhibit 31.2

                                  CERTIFICATION

I, Donald G. Barnhart, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of GoAmerica, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

      (a)  Designed  such  disclosure  controls and  procedures,  or caused such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

      (b) Evaluated the  effectiveness of the registrant's  disclosure  controls
and  procedures  and  presented  in  this  report  our  conclusions   about  the
effectiveness  of the disclosure  controls and procedures,  as of the end of the
period covered by this report based on such evaluation; and

      (c)  Disclosed  in this  report  any change in the  registrant's  internal
control over financial  reporting  that occurred  during the  registrant's  most
recent fiscal quarter (the registrant's  fourth fiscal quarter in the case of an
annual  report)  that  has  materially  affected,  or is  reasonably  likely  to
materially affect, the registrant's  internal control over financial  reporting;
and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's  auditors  and the audit  committee  of the  registrant's  board of
directors (or persons performing the equivalent functions):

      (a) All significant  deficiencies and material weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

      (b) Any fraud, whether or not material,  that involves management or other
employees who have a significant role in the registrant's  internal control over
financial reporting.

Date: August 14, 2007

                                 /s/ Donald G. Barnhart
                                 ----------------------
                                 Donald G. Barnhart
                                 Chief Financial Officer
USDA is an equal opportunity provider, employer, and lender.

USDA Extends Deadlines for ReConnect Rural Broadband Program

WASHINGTON, February 6, 2019 – Acting Administrator for USDA’s Rural Utilities Service Bette 

Brand announced today USDA would extend application deadlines for the Rural eConnectivity Pilot 

Program (ReConnect Program).

To give potential applicants adequate time to access technical assistance from USDA staff and its 

partners, the first application deadline will be pushed back to May 31, 2019 or later. Previously, 

application deadlines began in April. New specific deadlines for ReConnect Program grants, loans, 

and grant-loan combination applications will be posted in the Federal Register in late February.

“We’ve seen such strong interest in ReConnect from rural telecommunications providers and utility 

cooperatives, that we want to be sure there’s enough time for them to put solid applications together 

for these innovative funding opportunities,” said Bette Brand. “The USDA team stands ready to assist 

with engineering and business plans, to be sure these new Federal funds are as impactful as possible.”

As one part of that technical assistance, USDA is hosting a webinar with general information about the 

ReConnect program and guidance from experts for potential applicants. This webinar is open to the 

public and interested parties, and will be offered at 2:00 pm Eastern Time on both Thursday, February 

7 and Wednesday, February 13, 2019.

In March 2018, Congress provided $600 million to USDA to expand broadband infrastructure and 

services in rural America. On December 13, Agriculture Secretary Perdue announced the rules of the 

program, called “ReConnect”, including how the loans and grants will be awarded to help build 

broadband infrastructure in rural America. 

Telecommunications companies, rural electric cooperatives and utilities, internet service providers and 

municipalities may apply for funding through USDA’s new ReConnect Program to connect rural areas 

that currently have insufficient broadband service. Through the ReConnect Program, USDA is making 

available approximately $200 million for grants, as well as $200 million for loan and grant 

combinations, and $200 million for low-interest loans. Funds will be awarded to projects that have a 

financially-sustainable business models that will bring high-speed broadband to rural homes, 

businesses, farms, ranches, and community facilities such as first responders, healthcare sites, and 

schools.

More information about the ReConnect program may be found at http://reconnect.usda.gov.

# # #
UAS/UAV Aircraft Pre- Flight Check List

. Ensure that all parts and functions of UAV aircraft are in working condition. . Ensure that the remote controller, battery, and mobile device for controlling P hantom are fully charged. . Ensure that there is no foreign objects stuck in lens, micro sd card is inside camera, gimbal can rotate freely before powering on. . Ensure propellers are securely mounted and motors are starting functionally and normally. . Ensure signal to remote and UAV is conn ected and stable. Ensure auto return home flight is configured in event of loss of signal. . Calibrate compass and GPS for proposed flight. . Map proposed flight, parameters of flight, outline ideal flight trajectory and map out positions before flight..

Ensure DJI app, aircraft and controller firmware is updated to the latest version. . Ensure flight area is outside of no fly zones, in a permitted area. Check weather and wind conditions for permissible flight. . Observe local regulati ons, obtain appropriate authorization, and understand risks of flight.
§ 381.71 Condemnation on ante mortem inspection. ( a ) Birds plainly showing on ante mortem inspection any disease or condition, that under §§ 381.80 to 381.93, inclusive, would cause condemnation of their carcasses on post mortem inspection, shall be condemned. Birds which on ante mortem inspection are condemned shall not be dressed, nor shall they be conveyed into any department of the official establishment where poultry products are prepared or held. Poultry which has been condemned on ante mortem inspection and has been killed or died otherwise shall under the supervision of an inspector of the Inspection Service, be disposed of as provided in § 381.95.
( b ) Dead-on-arrival ratites and ratites condemned on ante mortem inspection will be tagged “U.S. Condemned” by an establishment employee under FSIS supervision and disposed of by one of the methods prescribed in § 381.95.
( c ) All seriously crippled ratites and non-ambulatory ratites, commonly termed “downers,” shall be identified as “U.S. Suspects.”
( d ) Ratites exhibiting signs of drug or chemical poisoning shall be withheld from slaughter.
( e ) Ratites identified as “U.S. Suspects” or “U.S. Condemned” may be set aside for treatment. The “U.S. Suspect” or “U.S. Condemned” identification device will be removed by an establishment employee under FSIS supervision following treatment if the bird is found to be free of disease. Such a bird found to have recovered from the condition for which it was treated may be released for slaughter or for purposes other than slaughter, provided that in the latter instance permission is first obtained from the local, State, or Federal sanitary official having jurisdiction over movement of such birds.
( f ) When it is necessary for humane reasons to slaughter an injured ratite at night or Sunday or a holiday, and the Agency veterinary medical officer cannot be obtained, the carcass and all parts shall be kept for inspection, with the head and all viscera except the gastrointestinal tract held by the natural attachment. If all parts are not so kept for inspection, the carcass shall be condemned. If on inspection of a carcass slaughtered in the absence of an inspector, any lesion or other evidence is found indicating that the bird was sick or diseased, or affected with any other condition requiring condemnation of the animal on ante mortem inspection, or if there is lacking evidence of the condition that rendered emergency slaughter necessary, the carcass shall be condemned. Ratites that are sick, dying, or that have been treated with a drug or chemical and presented for slaughter before the required withdrawal period, are not covered by emergency slaughter provisions.
[37 FR 9706, May 16, 1972, as amended at 66 FR 22906, May 7, 2001; 67 FR 13258, Mar. 22, 2002]
Exhibit 10.24
  SECOND
    AMENDED AND RESTATED EMPLOYMENT AGREEMENT
    WHEREAS,
  WHEREAS,
  NOW, THEREFORE
  Employment.
  Term of Employment.
  Employees Duties.
    Compensation.
  Base Compensation.
 1




---



##### 



Exhibit 10.24
    Annual Bonus.
  Long Term Incentive Awards.
            Additional Benefits.
  Expenses.
  Bonus.
 2




---



##### 



Exhibit 10.24
  Vacation.
  General Benefits.
  Flexible Perquisites; Use of Corporate
    Aircraft.
  Point of Origin; Relocation Expenses.
      Country Club Membership.
  Confidentiality; Nonsolicitation and
    Noncompete.
   3




---



##### 



Exhibit 10.24
  and/or and/or and/or and/or
        Termination.
    Resignation (other than for Good
    Reason).
  Death.
 4




---



##### 



Exhibit 10.24
    Discharge.
             5




---



##### 



Exhibit 10.24
          Disability.
        Resignation for Good
    Reason.
     6




---



##### 



Exhibit 10.24
      Resignation for Corporate
    Change.
    12-month
  12-month
  Notice of Termination.
 7




---



##### 



Exhibit 10.24
    Date of Termination, Etc.
  Mitigation.
  Excess Parachute
    Payments.
  Non exclusivity of
    Rights.
  Assignability.
  Notice.
 8




---



##### 



Exhibit 10.24
  Severability.
  Successors; Binding Agreement.
  and/or and/or
    Miscellaneous.
              Counterparts.
 9




---



##### 



Exhibit 10.24
  Arbitration.
  and/or and/or
   10




---



##### 



Exhibit 10.24
  IN WITNESS WHEREOF
    
  By:
    Gary P. Graphia,     Name:
    /s/ John Donofrio    1
From: Armstrong, Ashley [mailto:Ashley.Armstrong@EE.Doe.Gov]

Sent: Monday, April 11, 2011 11:00 AM

To: Armstrong, Ashley

Subject: Request for Information - Alternative Efficiency Determination Methods and Alternate Rating 

Methods

Good Afternoon,

The U.S. Department of Energy is announcing the issuance of a Notice requesting information 

and data related to the use of computer simulations, mathematical methods, and other 

alternative methods of determining the efficiency of certain types of consumer products and 

commercial and industrial equipment. The Request for Information is attached to this email 

and should be available on the Certification and Enforcement website shortly (See 

http://www.eere.energy.gov/buildings/appliance_standards/certification_enforcement.html.)

Best Regards,

Ashley
### §687h. Jurisdiction and service of process

Any suit or action brought under section 687, 687a, 687c, 687e, or 687g of this title by the Administration at law or in equity to enforce any liability or duty created by, or to enjoin any violation of, this chapter, or any rule, regulation, or order promulgated thereunder, shall be brought in the district wherein the licensee maintains its principal office, and process in such cases may be served in any district in which the defendant maintains its principal office or transacts business, or wherever the defendant may be found.

(Pub. L. 85–699, title III, §316, as added Pub. L. 89–779, §7, Nov. 6, 1966, 80 Stat. 1364.)

#### **Editorial Notes**

#### References in Text

For definition of "this chapter", referred to in text, see References in Text note set out under section 661 of this title.
### §4406. Preemption

#### (a) Federal action

Except as provided in the Family Smoking Prevention and Tobacco Control Act (and the amendments made by that Act), no statement relating to the use of smokeless tobacco products and health, other than the statements required by section 4402 of this title, shall be required by any Federal agency to appear on any package or in any advertisement (unless the advertisement is an outdoor billboard advertisement) of a smokeless tobacco product.

#### (b) State and local action

No statement relating to the use of smokeless tobacco products and health, other than the statements required by section 4402 of this title, shall be required by any State or local statute or regulation to be included on any package or in any advertisement (unless the advertisement is an outdoor billboard advertisement) of a smokeless tobacco product.

#### (c) Effect on liability law

Nothing in this chapter shall relieve any person from liability at common law or under State statutory law to any other person.

(Pub. L. 99–252, §7, Feb. 27, 1986, 100 Stat. 34; Pub. L. 111–31, div. A, title II, §205(b), June 22, 2009, 123 Stat. 1849.)

#### **Editorial Notes**

#### References in Text

The Family Smoking Prevention and Tobacco Control Act, referred to in subsec. (a), is div. A of Pub. L. 111–31, June 22, 2009, 123 Stat. 1776. For complete classification of this Act to the Code, see Short Title of 2009 Amendment note set out under section 301 of Title 21, Food and Drugs, and Tables.

#### Amendments

2009—Subsec. (a). Pub. L. 111–31 substituted "Except as provided in the Family Smoking Prevention and Tobacco Control Act (and the amendments made by that Act), no" for "No".
#### § 349.1 Notice to audited person.

An audit conducted by the Commission or its staff under authority of the Interstate Commerce Act may result in a notice of deficiency or audit report or similar document containing a finding or findings that the audited person has not complied with a requirement of the Commission with respect to, but not limited to, the following: A filed tariff or tariffs, contracts, data, records, accounts, books, communications or papers relevant to the audit of the audited person; and the activities or operations of the audited person. The notice of deficiency, audit report or similar document may also contain one or more proposed remedies that address findings of noncompliance. Where such findings, with or without proposed remedies, appear in a notice of deficiency, audit report or similar document, such document shall be provided to the audited person, and the finding or findings, and any proposed remedies, shall be noted and explained. The audited person shall timely indicate in a written response any and all findings or proposed remedies, or both, in any combination, with which the audited person disagrees. The audited person shall have 15 days from the date it is sent the notice of deficiency, audit report or similar document to provide a written response to the audit staff indicating any and all findings or proposed remedies, or both, in any combination, with which the audited person disagrees, and such further time as the audit staff may provide in writing to the audited person at the time the document is sent to the audited person. The audited person may move the Commission for additional time to provide a written response to the audit staff and such motion shall be granted for good cause shown. Any initial order that the Commission subsequently may issue with respect to the notice of deficiency, audit report or similar document shall note, but not address on the merits, the finding or findings, or the proposed remedy or remedies, or both, in any combination, with which the audited person disagreed. The Commission shall provide the audited person 30 days to respond to the initial Commission order concerning a notice of deficiency, audit report or similar document with respect to the finding or findings or any proposed remedy or remedies, or both, in any combination, with which it disagreed.

[Order 675-A, 71 FR 29785, May 24, 2006]